Interaction and nanotoxic effect of TiO 2 nanoparticle on fibrinogen by multi-spectroscopic method

Science of the Total Environment

Volumn 429, Issue , 2012, Pages 156-160

  Wang, Chao ^a   Li, Ying ^a  

^a HOHAI UNIVERSITY   (China)

Author keywords

Binding constant; Nanotoxicology; Protein nanoparticle interaction; TiO 2 nanoparticles

Indexed keywords

BINDING CONSTANT; CONFORMATIONAL CHANGE; COOPERATIVITY; DAILY LIVES; ENVIRONMENTAL EXPOSURE; FLUORESCENCE QUENCHING; FUNCTIONAL PROTEINS; HUMAN HEALTH; NANOTOXICOLOGY; PHOTOPHYSICAL MEASUREMENTS; PHYSICOCHEMICAL CHARACTERISTICS; PROTEIN-NANOPARTICLE INTERACTION; TIO; TOXICOLOGICAL EFFECTS;

BIOCHEMISTRY; INDUSTRIAL APPLICATIONS; NANOPARTICLES; PROTEINS; SPECTROSCOPIC ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY;

TITANIUM DIOXIDE;

FIBRINOGEN; NANOPARTICLE; TITANIUM DIOXIDE;

PARTICLE SIZE; PARTICULATE MATTER; PHYSICOCHEMICAL PROPERTY; PROTEIN; SPECTROSCOPY; TITANIUM; TOXICOLOGY;

ADSORPTION; ARTICLE; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DYNAMIC LIGHT SCATTERING; ENVIRONMENTAL EXPOSURE; FLUORESCENCE QUENCHING; NANOTOXICOLOGY; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; SPECTROSCOPY; TOXICITY TESTING; TRANSMISSION ELECTRON MICROSCOPY;

CIRCULAR DICHROISM; FIBRINOGEN; LIGHT; METAL NANOPARTICLES; MICROSCOPY, FLUORESCENCE; SCATTERING, RADIATION; SPECTROMETRY, FLUORESCENCE; TITANIUM;

EID: 84862263586     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2012.03.048     Document Type: Article

References (34)

1. Stephan H., Agmal S., Michael K., Silke H., Antje T., Katrin F., Christian G., Christian K., Rudolf H., Norbert K. Silver nanoparticles: evaluation of DNA damage, toxicity and functional impairment in human mesenchymal stem cells. Toxicol Lett 2011, 201:27-33.
2. Oberdörster G., Oberdörster E., Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005, 113:823-839.
3. Hackenberg S., Scherzed A., Kessler M., Froelich K., Ginzkey C., Koehler C., Burghartz M., Hagen R., Kleinsasser N. Zinc oxide nanoparticles induce photocatalytic cell death in human head and neck squamous cell carcinoma cell lines in vitro. Int J Oncol 2010, 37:1583-1590.
4. 2 with lysozyme: insights into the enzyme toxicity of nanosized particles. Environ Sci Pollut Res 2011, 17:798-806.
5. Bharali D.J., Klejbor I., Stachowiak E.K., Dutta P., Roy I., Kaur N., Bergey E.J., Prasad P.N., Stachowiak M.K. Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain. Proc Natl Acad Sci USA 2005, 102:11539-11544.
6. Oberdörster G. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J Intern Med 2010, 267:89-105.
7. Lin W.S., Huang Y.W., Zhou X.D., Ma Y.F. In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol Appl Pharmacol 2006, 217:252-259.
8. Fubini B., Ghiazza M., Fenoglio I. Physico-chemical features of engineered nanoparticles relevant to their toxicity. Nanotoxicology 2010, 4:347-363.
9. Clift M.J.D., Bhattacharjee S., Brown D.M., Vicki S. The effects of serum on the toxicity of manufactured nanoparticles. Toxicol Lett 2010, 198:358-365.
10. An H.J., Liu Q.D., Ji Q.L., Jin B. DNA binding and aggregation by carbon nanoparticles. Biochem Biophys Res Commun 2010, 393:571-576.
11. Petersen E.J., Nelson B.C. Mechanisms and measurements of nanomaterial -induced oxidative damage to DNA. Anal Bioanal Chem 2010, 398:613-650.
12. Schulze C., Schaefer U.F., Rugea C.A., Wohlleben W., Lehr C.M. Interaction of metal oxide nanoparticles with lung surfactant protein A. Eur J Pharm Biopharm 2011, 77:376-383.
13. Jie H., Jin B. DNA exposure to Buckminsterfullerene (C60): toward DNA stability, reactivity, and replication. Environ Sci Technol 2011, 45:6608-6616.
14. Mahtab R., Sealey S.M., Hunyadi S.E., Kinard B., Ray T., Murphy C.J. Influence of the nature of quantum dot surface cations on interactions with DNA. J Inorg Biochem 2007, 101:559-564.
15. Xu Z., Wang S.L., Gao H.W. Effects of nano-sized silicon dioxide on the structures and activities of three functional proteins. J Hazard Mater 2010, 180:375-383.
16. Cedervall T., Lynch I., Lindman S., Berggård T., Thulin E., Nilsson H., Dawson K.A., Linse S. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci USA 2007, 104:2050-2055.
17. Shen X.C., Liou X.Y., Ye L.P., Liang H., Wang Z.Y. Spectroscopic studies on the interaction between human hemoglobin and Cd quantum dots. J Colloid Interface Sci 2007, 311:400-406.
18. Lacerda S.H.D.P., Park J.J., Meuse C., Pristinski D., Becker M.L., Karim A., Douglas J.F. Interaction of gold nanoparticles with common human blood proteins. ACS Nano 2010, 4:365-379.
19. Hassana N., Rusoa J.M., Somasundaran P. Mechanisms of fibrinogen-acebutolol interactions: insights from DSC, CD and LS. Colloids Surf B 2011, 82:581-587.
20. Brown J.H., Volkmann N., Jun G., Henschen-Edman A.H., Cohen C. The crystal structure of modified bovine fibrinogen. Proc Natl Acad Sci USA 2000, 97:85-90.
21. Yakovlev S., Medved L. Interaction of fibrin(ogen) with the endothelial cell receptor VE-cadherin: localization of the fibrin-binding site within the third extracellular VE-Cadherin domain. Biochemistry 2009, 48:5171-5179.
22. Tsurupa G., Hantgan R.R., Burton R.A., Pechik I., Tjandra N., Medved L. Structure, stability, and interaction of the fibrin(ogen) αC-domains. Biochemistry 2009, 48:12191-12201.
23. Naik P.N., Chimatadar S.A., Nandibewoor S.T. Interaction between a potent corticosteroid drug - dexamethasone with bovine serum albumin and human serum albumin: a fluorescence quenching and fourier transformation infrared spectroscopy study. J Photochem Photobiol B 2010, 100:147-159.
24. Iosin M., Toderas F., Baldeck P.L., Astilean S. Study of protein-gold nanoparticle conjugates by fluorescence and surface-enhanced Raman scattering. J Mol Struct 2009, 924-926:196-200.
25. Wang Q., Zhang Y.H., Sun H.J., Chen H.L., Chen X.G. Study of interaction of butyl p-hydroxybenzoate with human serum albumin by molecular modeling and multi-spectroscopic method. J Lumin 2011, 131:206-211.
26. Yuan T., Weljie A.M., Vogel H.J. Tryptophan fluorescence quenching by methionine and selenomethionine residues of calmodulin: orientation of peptide and protein binding. Biochemistry 1998, 37:3187-3195.
27. Scatchard G. The attractions of protein for small molecules and ions. Ann NY Acad Sci 1949, 51:660-673.
28. 2 with human serum albumin: a fluorescence quenching study. Colloids Surf A 2009, 333:91-95.
29. Trynda-Lemiesz L., Karaczyn A., Keppler B.K., Koztowski H. Studies on the interactions between human serum albumin and transindazolium (bisindazole) tetrachlororuthenate(III). J Inorg Biochem 2000, 78:341-346.
30. Yang P., Gao F. The principle of bioinorganic chemistry 2002, 349. Science Press, Beijing, China.
31. He W.Y., Li Y., Tang J.H., Luan F., Jin J., Hu Z.D. Comparison of the characterization on binding of alpinetin and cardamonin to lysozyme by spectroscopic methods. Int J Biol Macromol 2007, 39:165-173.
32. Powers K.W., Brown S.C., Krishna V.B., Wasdo S.C., Moudgil B.M., Roberts S.M. Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol Sci 2006, 90:296-303.
33. Clogston J.D., Ayub N., Aggarwal P., Neun B.W., Hall J.B., McNeil S.E. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomed Nanotechnol Biol Med 2009, 5:106-117.
34. Borm P.J., Robbins D., Haubold S., Kuhlbusch T., Fissan H., Donaldson K., Schins R., Stone V., Kreyling W., Lademann J., Krutmann J., Warheit D., Oberdorster E. The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol 2006, 3:11.